Clinical Trials Browser

Phase 1/2 × Ovarian Neoplasms × abagovomab × Clear all

NCT00103545 2006-10-02

Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response

Phase 1/2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms